Cigarette smoke comprises a large number of carcinogenic substances that can increase DNA mutation load in epithelial cells of the mouth, throat and lungs. While a strong C:A substitution preference is abundant in tobacco-related cancer genomes, detection of complex or less abundant somatic mutation signatures may be confounded by the heterogeneity of carcinogens present in smoke. Trinucleotide signatures are defined for a variety of somatic mutation processes, yet the extent to which this configuration optimally defines and discriminates between mutational processes is not clear. Here, we describe a method that determines whether trinucleotide patterns do a good job at encapsulating a mutation signature or whether they mask underlying heterogeneity that alternative pattern structures would better define. The approach works by mapping the dependency of trinucleotide signatures in relation to sequence context to establish a 'footprint' of context dependency. Applying this technique to smoke-associated cancers, we show that a robust tetranucleotide substitution is prevalent in 17% of lung squamous cell carcinoma genomes. The signature is dominated by the substitution CT(C:A)G and is strongly associated with gene expression level and intron-exon junctions. Intriguingly, its distribution across the genome is biased towards 5′ splice junctions, suggesting a novel mechanism of mutation.
Introduction
Over 60 carcinogenic substances are present in the aerosol of a cigarette, predisposing to multiple cancer types and to 27% of all cancer-related deaths in the USA in 2016 (1, 2) . Studies of smoke-related somatic mutations in the p53 gene, a key driver gene of lung cancer, have identified multiple substitution preferences that correspond to specific carcinogens (3) . The transition preference C:A is particularly common and arises through the erroneous repair of DNA adducts that form when metabolites of the carcinogen benzo(a)pyrene, prevalent in cigarettes, intercalate with DNA (3).
Non-negative matrix factorization (NMF) is a powerful dimensional reduction algorithm that can extract characteristic signatures from nucleotide sequence data (4) . The procedure is constrained to the detection of very short signatures-typically trinucleotide signatures-since variability in the signatures detected increases exponentially with signature length. By evaluating the sequence context of single base substitutions using NMF, trinucleotide signatures of somatic mutation have been attributed to many mutational processes in human cancers (5, 6) .
Despite the presence of numerous carcinogens in cigarette smoke, smoke-related mutation signatures that substantially refine the C:A transition preference have not been detected (5, 7, 8) . One reason for this may be that the heterogeneity of carcinogens in smoke effectively masks any individual mutation signature. In principle, the substitution preferences of some carcinogens might not be well resolved using trinucleotide signatures, and alternative signature structures that incorporate additional flanking nucleotides could be advantageous. To determine whether this is the case, we developed an NMF-based approach to map the footprint of context sensitivity for trinucleotide signatures.
Using this technique, we further refined our understanding of smoke-associated mutational processes and characterized a somatic mutation signature prevalent in lung cancer that exhibits robust tetranucleotide structure.
Materials and methods

Non-negative matrix factorization
The NMF algorithm was used to extract trinucleotide somatic mutation signatures of the form N −1 (N 0 :N mut )N +1 , where the superscript denotes position relative to the mutated base, as described previously (5) . Tetranucleotide somatic mutation signatures of the form N −6..−2 N −1 (N 0 :N mut ) N +1 or N −1 (N 0 :N mut )N +1 N +2..+6 were extracted using the same process. The NMF was performed using the R package NMF (9) . Cluster stability as a function of rank (cluster number) was determined using 1000 NMF runs per rank.
Signature alignment
Context-dependent trinucleotide NMF signatures were aligned to a set of context-independent reference signatures by comparing cosine similarity scores between signatures. The reference signatures were generated by performing NMF on the complete set of substitutions. Matches between context-dependent signatures and reference signatures were selected based on the maximal cosine similarity score. Alignment conflicts were resolved by prioritizing the highest scoring matches first.
Analysis of signature variance in relation to context
Trinucleotide signature variance is defined as the median of the variances of each trinucleotide coefficient in the signature. Variance for an individual trinucleotide is calculated as the variance between the four NMF coefficients corresponding to each possible nucleotide at a given flanking position. For example, the trinucleotide substitution A(A:C)A in relation to position −2 has four NMF coefficients corresponding to GA(A:C)A, CA(A:C)A, TA(A:C)A and AA(A:C)A. Signatures that are context-agnostic at position −2 will exhibit low variance within this group of NMF coefficients compared with signatures that are context-dependent at position −2. Signature variances were determined for 100 000 NMF runs with random start conditions.
Data sets
Somatic mutation and RNAseq data sets were downloaded from the cancer genome atlas (TCGA). Somatic mutation TCGA data set ids are as follows: DNASeq.Level_2.0.2.0 (LUAD), DNASeq.Level_2.1.0.0 (HNSC), DNASeq.Level_2.1.4.0 (LUSC). RNAseq data set ids are as follows: RNASeqV2.Level_3.1.4.0 (HNSC), RNASeqV2.Level_3.1.2.0 (LUSC), RNASeqV2.Level_3.1.7.0 (LUAD). Exome trinucleotide and tetranucleotide frequencies were calculated using all exons defined in the Ensembl grch37 human genome assembly.
Signature validation
NMF can potentially detect sequencing artefacts in addition to valid signatures of mutagenic processes. To validate that the Smoking-B signature represents a genuine somatic mutation, we manually examined BAM (Binary sequence Alignment/Map) files corresponding to the top five patient specimens that exhibited the Smoking-B signature and confirmed that the major Smoking-B tetranucleotide substitutions are consistently sequenced in both forward and reverse directions in overlapping read pairs and in reads originating from distinct genomic fragments. Ten sample exome alignments of the signature isolated from a single patient TCGA-85-6561 are included in Supplementary data, available at Carginogenesis Online, demonstrating that the signature is frequent and not associated with repetitive elements.
Results
The stability of trinucleotide somatic mutation signatures is context dependent We applied trinucleotide NMF to the combined mutation profiles of lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC) and head and neck squamous cell carcinoma (HNSC). This process yielded five trinucleotide signatures that have been Figure  S1 , available at Carcinogenesis Online), which was previously noted by Jia et al. (10) .
To assess the range of context sensitivity for somatic mutation processes, we developed an algorithm for statistically measuring the sensitivity of each trinucleotide signature to sequence variation at flanking nucleotide positions ( Figure 1 ). This approach allows us to test whether a somatic substitution preference is well encapsulated by a trinucleotide signature. Significant sensitivity to flanking nucleotide positions could be indicative of a heterogeneous signature and would suggest alternative signature configurations that may improve detection of mutational processes. Note that this strategy for detecting context dependency is not exhaustive as it detects only direct interactions between the trinucleotide and flanking positions outside of the central trinucleotide; complex interactions between multiple flanking nucleotides are not considered.
Applying our algorithm to somatic mutation profiles from smoking-associated cancer genomes (downloaded from the TCGA), we observed significant context sensitivity for the 'Kataegis' signature, the Smoking-A signature and the Smoking-B signature ( Figure 2 ). Conversely, the signature for UV light exposure (present in HNSC) and two other signatures defined by Alexandrov et al. (5) did not exhibit significant context sensitivity (Figure 2 ), suggesting that these substitution preferences are well encapsulated by trinucleotide signatures.
Context dependency of the Kataegis signature
Of the six signatures tested, the signature for Kataegis showed the greatest context-dependent variability (P < 5 × 10 −6 ), with strong bias measured at positions −2, +2 and +3 relative to the substitution ( 
Context dependency of the Smoking-B signature
A second smoke-related trinucleotide signature, common to LUSC genomes, exhibits frequent C:A substitutions, ('Smoking-B'; Figure 3A and Supplementary Figure S6A , available at Carcinogenesis Online). We found that the Smoking-B Mapping the footprint of somatic mutation signatures in smoking-related cancers. Sensitivity of trinucleotide somatic mutation signatures to variation in flanking nucleotides was determined for three smoking-associated cancer types using the procedure described in Figure 1 . Signature variance levels correspond to the average context-dependent variance measured for each flanking position in 10 5 NMF iterations. P-values were calculated as described in Figure 1D . *P < 0.05; **P < 5 × 10 −3 ; ***P < 5 × 10 −4 ; ****P < 5 × 10 −5 ; *****P < 5 × 10 −6 . signature exhibits strong context sensitivity (P < 5 × 10 −6 ) at position −2 relative to the substitution (Figure 2 ). Extracting the equivalent tetranucleotide Smoking-B signature [−2, −1, 0, +1] revealed a qualitative shift in site specificity depending on the nucleotide at position −2 ( Figure 3B ). When normalized to nucleotide frequencies of the human exome, the substitution CT(C:A)G emerges as the overwhelming substitution preference for the Smoking-B signature (Supplementary Figure S6B and C, available at Carcinogenesis Online). Validation of the signature was performed as described in Methods.
Prevalence of the Smoking-B signature in human cancer
We next examined the prevalence of the Smoking-B signature in HNSC, LUAD and LUSC tumours. This signature was more prevalent than the Smoking-A signature in 31 of 177 LUSC samples. In patients with high levels of the Smoking-B signature, it is typically the dominant somatic mutation signature ( Figure 4A) . Occurrence of the Smoking-B signature in HNSC and LUAD was low (data not shown).
Smoking contributes to a variety of cancer types in addition to LUAD, LUSC and HNSC, albeit at lower frequency. To assess the prevalence of the Smoking-B signature in other cancer types, we correlated the Smoking-B signature with tetranucleotide mutation profiles for 15 different tumour sites ( Figure 4B ). The signature proved remarkably specific to LUSC, which comprised 19 of the 20 samples most strongly correlated with the Smoking-B signature. The signature was also detected at R > 0.4 in 5 of 293 kidney renal clear-cell carcinoma (KIRC) specimens ( Figure 4B ), including one with R = 0.88 ( Figure 4B -see KIRC patient in second position from top). CT(C:A)G was the most prevalent tetranucleotide substitution in this tumour specimen, followed by other substitutions characteristic of the Smoking-B signature (data not shown).
We conclude that the Smoking-B signature occurs mainly in LUSC and occasionally in KIRC. As smoking is a known risk factor for KIRC, smoke-related carcinogens remain the probable cause of the Smoking-B signature (11) .
Association of the Smoking-B signature with gene-specific parameters
Considering the distinctive tetranucleotide bias of the Smoking-B signature, we reasoned that tumours displaying the signature at high frequency (SB high ) are likely to be enriched for the causative carcinogenic process(es). Conversely, patients exhibiting low frequencies of the Smoking-B signature (SB low ) are less likely to have acquired any given mutation via a specific process. By comparing the Smoking-B target genes in SB high versus SB low LUSC patients, we aimed to assess whether specific gene properties are associated with the mutagenic process ( Table 1) . We found the Smoking-B signature to associate very significantly with heightened gene expression (P < 2 × 10 Figure 5A ) and with structural parameters including number of exons (P = 3 × 10 −5 ) and number of transcript isoforms (P = 1 × 10 −8
). This was also consistent for the SB high KIRC specimen (data not shown). In contrast, the Smoking-A signature did not show association with these parameters (Table 1) . This suggests that distinct transcriptional mechanisms may contribute to Smoking-B substitutions.
We next tested whether the association between gene expression level and Smoking-B mutation might be restricted to specific tetranucleotide sequences. We examined whether average expression levels of specific transcripts are associated with tetranucleotide sequences specific for either the Smoking-A or Smoking-B signatures ( Figure 5B ). Only the CT(C:A)G and AC(C:A)A tetranucleotides were significantly associated with differential expression of target genes (P < 1 × 10 −14 and P < 1 × 10 −6 respectively). CT(C:A)G is the predominant substitution in the Smoking-B signature (Supplementary Figure S6B , available at Carcinogenesis Online), thus further implicating transcriptional mechanisms in causing this somatic mutation pattern.
Intriguingly, Smoking-B mutations showed association with number of exons per gene, but not with total gene length ( Table 1) . This apparent paradox could be resolved if exon-specific structural elements contributed to the somatic mutation process. We therefore examined the incidence of Smoking-B mutations relative to the boundaries of each target exon. In SB high tumours, a clear bias for mutations at exon boundaries was apparent, with Smoking-B substitutions occurring significantly closer to the start (P = 1.2 × 10 −8
) and end (P = 3.9 × 10 −3 ) of Significant differences between gene metric distributions were determined for LUSC patients with high frequencies (top 10%) versus low frequencies (bottom 10%)
for each signature. Significance was determined using the Wilcoxon rank-sum test. target exons than in the wider TCGA tumour dataset (median of 17 bp and 8 bp, respectively; Supplementary Table S1, available at Carcinogenesis Online). The most prevalent Smoking-B substitution, CT(C:A)G, exhibited the most significant bias towards both the start and end of target exons ( Figure 5A ). This suggests an association between Smoking-B mutation and a molecular process that operates at exon/intron boundaries. The bias towards exon boundaries is also strand-dependent, with the greatest increase in substitution frequency occurring in the forward orientation (plus, or transcribed strand) within the first 20 bp of the exon ( Figure 5B, top-left panel) . In contrast, the frequencies of reverse-orientation (minus strand) substitutions do not differ significantly at exon ends in SB high tumours ( Figure 5B, bottom-right panel) . Taken together, these findings suggest that Smoking-B mutation is mediated via transcriptional processes taking place at the leading edge of exons on the forward strand.
Discussion
Somatic mutational processes display clear contextual preferences and have been investigated in depth within a trinucleotide context to yield numerous 'signatures' of somatic mutation (5, 10) . Here, we extend the analysis by systematically assessing the contribution of flanking nucleotides to somatic mutation processes through concurrent evaluation of tetranucleotide and trinucleotide NMF signatures. This approach allowed us to map the footprints of site specificity for major somatic mutation processes in smoke-associated cancers. Substantial departure from previously described trinucleotide somatic mutation signatures was not observed in most cases, including UV light (HNSC), Smoking-A and two additional signatures defined by Alexandrov et al. ('Signature 5' and 'Signature 1A/1B') when adjusting for exome wide frequencies. However, a very strong tetranucleotide signature was observed for the Smoking-B signature, facilitating more precise discrimination from the Smoking-A signature, both of which are characterised by a C:A substitution.
Both the Smoking-A and Smoking-B signatures exhibited transcriptional strand bias in LUSC patients. However, only the Smoking-B signature showed association with other genespecific parameters including increased expression level and splicing complexity. Exploring the distribution of Smoking-B mutations in the context of target exons revealed a marked bias towards the start of exons in the forwards orientation, implicating processes localized to the 5′ splice junction on the transcribed strand in contributing to somatic mutation.
What process might bring about the enrichment of Smoking-B mutations at transcribed-strand intron-exon junctions? A possible explanation relates to the pausing of RNApolII at 5′ splice sites (12) , which are located at the junction in question. Transcriptional pausing is widespread in the mammalian genome and localized preferentially to exons via positioning of nucleosomes, although localization within the exon has not been defined. In yeast, however, pausing of RNA polymerase has been pinpointed to the 5′-intron-exon-3′ junction and is associated with gene splicing (13) . Assuming that RNA polymerase pausing at the 5′ splice site is conserved in mammalian cells, this would explain the enriched mutational burden at this position.
Conclusions
We developed an approach for mapping the footprints of somatic mutation processes and applied it to the gene mutation profiles of smoking-associated cancers. This yielded a robust tetranucleotide somatic mutation signature present in 17% of LUSC tumour genomes. The signature associates with transcription direction, transcription level and was preferentially localized to the leading edge of transcribed exons on the forward strand. The process of splicing-associated transcriptional pausing is a potential explanation for this distribution of mutations.
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